Ertugliflozin ameliorates experimentally-induced colitis in rats by regulating the interplay between M1/M2 macrophage polarization, tight junction proteins, and MicroRNA 155 expression
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.115505 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Marina R Fouad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate program in Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Egypt; Clinical Pharmacy Department, Faculty of Pharmacy,…. Hauptthemen laut MEDLINE: MicroRNAs, Macrophages, Sodium-Glucose Transporter 2 Inhibitors, Bridged Bicyclo Compounds, Heterocyclic. Die Arbeit nennt 98 Literaturangaben.
Abstract (Originalsprache)
Ulcerative colitis (UC) is a persistent inflammatory condition marked by the destruction of the intestinal mucosal barrier, infiltration of inflammatory cells, and ulceration. M1/M2 macrophage polarization plays an imperative function in the regulation of inflammation through the nuclear factor-kappa B (NFκB) signaling pathway and modulating microRNA-155 (miR-155). Recent studies have highlighted the anti-ulcerogenic and colo-protective properties of sodium-glucose co-transporter-2 (SGLT2) inhibitors. However, the potential protective and therapeutic effects of ertugliflozin (Ertu), an SGLT2 inhibitor, in UC have not yet been clarified. Therefore, the present research sought to investigate the potential role of Ertu in mitigating acetic acid (AA)-induced UC in rats. Forty-two adult Wistar rats were allocated into seven groups: control, Ertu (10 mg/kg), AA, AA+ Ertu (1, 5, and 10 mg/kg), and AA+ sulfasalazine (Sulfa) (100 mg/kg); all received oral treatments daily for 7 days. Pre-treatment with Ertu mitigated histopathological alterations and enhanced macroscopic assessments. Ertu suppressed the expression of NF-κB p65 and miRNA-155, promoting macrophage polarization towards M2 phenotype, as witnessed by increased expression of CD206, Fizz-1, Ym-1, and Arg-1, along with elevated IL-10 protein content. It reduced the expression of CD86 and MCP-1, besides the levels of TNF-α, IL-1β and iNOS. Moreover, Ertu improved intestinal epithelial integrity by upregulating tight junction proteins, comprising claudin-1, occludin and ZO-1. Ertu also demonstrated anti-apoptotic effects by reducing BAX meanwhile increasing BCL2. Notably, Ertu (10 mg/kg) exhibited therapeutic effects comparable to the standard treatment, Sulfa, underscoring its potential as a distinctive and valuable option for UC management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Postgraduate program in Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Egypt; Clinical Pharmacy Department, Faculty of Pharmacy, Misr International University (MIU), Cairo, Egypt. Electronic address…
- Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: mostafa.mohammed@pharma.cu.edu.eg.
- Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: hala.fahmy@pharma.cu.edu.eg.
- Clinical Pharmacy Department, School of Pharmacy, Newgiza University, Giza, Egypt. Electronic address: rania.salama@ngu.edu.eg.
Zitieren
APA
Fouad, M. R., Rabie, M. A., Zaki, H. F., & Salama, R. M. (2025). Ertugliflozin ameliorates experimentally-induced colitis in rats by regulating the interplay between M1/M2 macrophage polarization, tight junction proteins, and MicroRNA 155 expression. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115505
Vancouver
Fouad MR, Rabie MA, Zaki HF, Salama RM. Ertugliflozin ameliorates experimentally-induced colitis in rats by regulating the interplay between M1/M2 macrophage polarization, tight junction proteins, and MicroRNA 155 expression. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115505
BibTeX
@article{Fouad2025,
author = {Fouad, Marina R and Rabie, Mostafa A and Zaki, Hala F and Salama, Rania M},
title = {Ertugliflozin ameliorates experimentally-induced colitis in rats by regulating the interplay between M1/M2 macrophage polarization, tight junction proteins, and MicroRNA 155 expression},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.115505}
}
EUVIMED